ArticleGut2002
Molecular characteristics of serrated adenomas of the colorectum.
Article in Gut, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 94 citations in OpenAlex.
- Importance of sessile serrated lesions in a patient with familial adenomatous polyposis.Clinical journal of gastroenterology · 2021Article
- Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.International journal of colorectal disease · 2020Article
- Whole-exome sequencing identified mutational profiles of high-grade colon adenomas.Oncotarget · 2017Article
- Frequent CpG island methylation: a risk factor in the progression of traditional serrated adenoma of the colorectum.International journal of clinical and experimental pathology · 2017Article
- Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.Gastroenterology · 2015Review
- BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications.Oncotarget · 2014Review
- Risk factors for serrated polyps of the colorectum.Digestive diseases and sciences · 2014Review
- Protein-protein interaction analysis of distinct molecular pathways in two subtypes of colorectal carcinoma.Molecular medicine reports · 2014Article
- Invasive adenocarcinoma arising from a mixed hyperplastic/adenomatous polyp and synchronous transverse colon cancer.World journal of surgical oncology · 2013Article
- Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management.Journal of gastroenterology · 2013Review
- Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract.International journal of cancer · 2011Article
- APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2011Article
- Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.Histopathology · 2011Article
- Retained cell–cell adhesion in serrated neoplastic pathway as opposed to conventional colorectal adenomas.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2011Article
- Serrated polyposis: an enigmatic model of colorectal cancer predisposition.Pathology research international · 2011Article
- Article
- Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma.International journal of colorectal disease · 2010Article
- BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?BMC cancer · 2008Article
- Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.Oncogene · 2007Article
- Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.Histopathology · 2006Article
Corrections and comments
- Commented on by
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerrated adenomas (SAs) of the colorectum combine architectural features of hyperplastic polyps and cytological features of classical adenomas. Molecular studies comparing SAs and classical adenomas suggest that each may be a distinct entity; in particular, it has been proposed that microsatellite instability (MSI) distinguishes SAs from classical adenomas and that SAs and the colorectal cancers arising from them develop along a pathway driven by low level microsatellite instability (MSI-L).
aimsTo define the molecular characteristics of SAs of the colorectum. MATERIALS AND
methodsWe analysed 39 SAs from 27 patients, including eight SAs from patients with familial adenomatous polyposis (FAP). We screened these polyps for selected molecular changes, including loss of heterozygosity (LOH) close to APC (5q21) and CRAC1 (15q13-q22), MSI, and mutations of K-ras, APC, p53, and beta-catenin. Expression patterns of beta-catenin, p53, MLH1, MSH2, E-cadherin, and O(6)-methylguanine DNA methyltransferase (MGMT) were assessed by immunohistochemistry. Comparative genomic hybridisation was performed on several polyps.
resultsMSI was rare (<5% cases) and there was no loss of expression of mismatch repair proteins. Wnt pathway abnormalities (APC mutation/LOH, beta-catenin mutation/nuclear expression) occurred in 11 SAs, including 6/31 (19%) non-FAP tumours. CRAC1 LOH occurred in 23% of tumours. K-ras mutations and p53 mutations/overexpression were found in 15% and 8% of SAs, respectively. Loss of MGMT expression occurred in 18% of polyps and showed a borderline association with K-ras mutations. Aberrant E-cadherin expression was found in seven polyps. Comparative genomic hybridisation detected no gains or deletions of chromosomal material.
conclusionsThe serrated pathway of colorectal tumorigenesis appears to be heterogeneous. In common with classical adenomas, some SAs develop along pathways involving changes in APC/beta-catenin. SAs rarely show MSI or any evidence of chromosomal-scale genetic instability. K-ras mutations may however be less common in SAs than in classical adenomas. Some SAs may harbour changes in the CRAC1 gene. Changes in known genes do not account for the growth of the majority of SAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.